CRISPR/Cas9‑mediated cervical cancer treatment targeting human papillomavirus E6
Takahiro Yoshiba(Jichi Medical University), Hiroaki Mizukami(Jichi Medical University)
Cited by 108
Related Papers
Fear-enhancing effects of septal oxytocin receptors
|Nature Neuroscience|2013|215
Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16�E6/E7
|International Journal of Oncology|2018|25